Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates
- PMID: 24287719
- PMCID: PMC3988539
- DOI: 10.1038/npp.2013.331
Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates
Abstract
Serotonin (5-HT) transporter (SERT) substrates like fenfluramine and 3,4-methylenedioxymethamphetamine cause long-term depletion of brain 5-HT, while certain other substrates do not. The 5-HT deficits produced by SERT substrates are dependent upon transporter proteins, but the exact mechanisms responsible are unclear. Here, we compared the pharmacology of several SERT substrates: fenfluramine, d-fenfluramine, 1-(m-chlorophenyl)piperazine (mCPP) and 1-(m-trifluoromethylphenyl)piperainze (TFMPP), to establish relationships between acute drug mechanisms and the propensity for long-term 5-HT depletions. In vivo microdialysis was carried out in rat nucleus accumbens to examine acute 5-HT release and long-term depletion in the same subjects. In vitro assays were performed to measure efflux of [(3)H]5-HT in rat brain synaptosomes and transporter-mediated ionic currents in SERT-expressing Xenopus oocytes. When administered repeatedly to rats (6 mg/kg, i.p., four doses), all drugs produce large sustained elevations in extracellular 5-HT (>5-fold) with minimal effects on dopamine. Importantly, 2 weeks after dosing, only rats exposed to fenfluramine and d-fenfluramine display depletion of brain 5-HT. All test drugs evoke fluoxetine-sensitive efflux of [(3)H]5-HT from synaptosomes, but d-fenfluramine and its bioactive metabolite d-norfenfluramine induce significantly greater SERT-mediated currents than phenylpiperazines. Our data confirm that drug-induced 5-HT release probably does not mediate 5-HT depletion. However, the magnitude of transporter-mediated inward current may be a critical factor in the cascade of events leading to 5-HT deficits. This hypothesis warrants further study, especially given the growing popularity of designer drugs that target SERT.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3988539/bin/npp2013331f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3988539/bin/npp2013331f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3988539/bin/npp2013331f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3988539/bin/npp2013331f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3988539/bin/npp2013331f5.gif)
Similar articles
-
1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.Neuropsychopharmacology. 2001 May;24(5):492-501. doi: 10.1016/S0893-133X(00)00221-9. Neuropsychopharmacology. 2001. PMID: 11282249
-
Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.Ann N Y Acad Sci. 2000 Sep;914:172-86. doi: 10.1111/j.1749-6632.2000.tb05194.x. Ann N Y Acad Sci. 2000. PMID: 11085319
-
Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.Synapse. 2003 Dec 1;50(3):212-22. doi: 10.1002/syn.10262. Synapse. 2003. PMID: 14515339
-
Therapeutic and adverse actions of serotonin transporter substrates.Pharmacol Ther. 2002 Jul;95(1):73-88. doi: 10.1016/s0163-7258(02)00234-6. Pharmacol Ther. 2002. PMID: 12163129 Review.
-
Serotonin releasing agents. Neurochemical, therapeutic and adverse effects.Pharmacol Biochem Behav. 2002 Apr;71(4):825-36. doi: 10.1016/s0091-3057(01)00669-4. Pharmacol Biochem Behav. 2002. PMID: 11888573 Review.
Cited by
-
Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome.Epilepsia Open. 2024 Feb;9(1):300-313. doi: 10.1002/epi4.12873. Epub 2023 Dec 22. Epilepsia Open. 2024. PMID: 38018342 Free PMC article.
-
Fenfluramine: a plethora of mechanisms?Front Pharmacol. 2023 May 12;14:1192022. doi: 10.3389/fphar.2023.1192022. eCollection 2023. Front Pharmacol. 2023. PMID: 37251322 Free PMC article. Review.
-
Seizures Cause Prolonged Impairment of Ventilation, CO2 Chemoreception and Thermoregulation.J Neurosci. 2023 Jul 5;43(27):4959-4971. doi: 10.1523/JNEUROSCI.0450-23.2023. Epub 2023 May 9. J Neurosci. 2023. PMID: 37160367 Free PMC article.
-
A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA).Curr Res Toxicol. 2022 May 19;3:100075. doi: 10.1016/j.crtox.2022.100075. eCollection 2022. Curr Res Toxicol. 2022. PMID: 35651589 Free PMC article.
-
An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies.Int J Mol Sci. 2021 Aug 5;22(16):8416. doi: 10.3390/ijms22168416. Int J Mol Sci. 2021. PMID: 34445144 Free PMC article. Review.
References
-
- Appel NM, Mitchell WM, Contrera JF, De Souza EB. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse. 1990;6:33–44. - PubMed
-
- Auerbach SB, Kamalakannan N, Rutter JJ. TFMPP and RU24969 enhance serotonin release from rat hippocampus. Eur J Pharmacol. 1990;190:51–57. - PubMed
-
- Baumann MH, Ayestas MA, Dersch CM, Rothman RB. 1-(M-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Neuropsychopharmacology. 2001;24:492–501. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources